Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D05TYV
|
||||
Former ID |
DIB001221
|
||||
Drug Name |
CXCR3 antagonists
|
||||
Synonyms |
CXCR3 antagonists (inflammatory diseases); CXCR3 antagonists (inflammatory diseases), GlaxoSmithKline
|
||||
Indication | Inflammatory disease [ICD9: 140-229, 147, 173, 573.3, 710-719; ICD10:C11, C44, K75.9, M00-M25] | Investigative | [552132] | ||
Company |
GlaxoSmithKline plc
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
FC(F)(c1cnc(N2[C@H](CN(S(=O)(=O)C[C@]34C(C)(C)[C@H](CC3<br />)C[C@@H]4O)CC2)C)c(c1)F)F
|
||||
Target and Pathway | |||||
Target(s) | C-X-C chemokine receptor type 3 | Target Info | Antagonist | [543922] | |
NetPath Pathway | IL2 Signaling Pathway | ||||
Pathway Interaction Database | CXCR3-mediated signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.